Low-grade endometrial stromal sarcoma: Hormonal aspects

Gynecologic Oncology

Volumn 90, Issue 1, 2003, Pages 170-176

  Chu, Micheline C ^a   Mor, Gil ^a   Lim, Chungyun ^a   Zheng, Wenxin ^a   Parkash, Vinita ^a   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MESSENGER RNA; PROGESTERONE RECEPTOR; ESTROGEN RECEPTOR;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER TISSUE; DISEASE ACTIVITY; ENDOMETRIUM SARCOMA; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; STROMA CELL; TREATMENT OUTCOME; ARTICLE; BIOSYNTHESIS; CANCER STAGING; CHEMICALLY INDUCED DISORDER; ENDOMETRIUM TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SARCOMA, ENDOMETRIAL STROMAL;

EID: 0037824470     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00258-0     Document Type: Article

References (32)

1. Koss L., Spiro R.H., Brunschwig A. Endolymphatic stromal myosis a grade 1 endometrial sarcoma . Gynecol Oncol. 1:1973;299-313.
2. Barakat R. Contemporary issues in the management of endometrial cancer. Ca Cancer J Clin. 48:1998;299-314.
3. Norris H.T., Tavasolli H.B. Mesenchymal tumors of the uterus a clinical and pathological study of 53 endometrial stromal tumors . Cancer. 19:1966;755-766.
4. Chang K., Crabtree G.S., Lim-Tan S.K., Kempson R.L., Hendrickson M.R. Primary uterine endometrial stromal neoplasms a clinicopathologic study of 117 cases . Am J Surg Pathol. 14:1990;415-438.
5. Piver M., Rutledge F.N., Copeland L., Webster K., Blumenson L., Suh O. Uterine endolymphatic stromal myosis a collaborative study . Obstet Gynecol. 64:1984;173-178.
6. Reich O., Regauer S., Urdl W., Lahousen M., Winter R. Expression of oestrogen and progesterone receptors in low grade endometrial stromal sarcomas. Br J Cancer. 82:2000;1030-1034.
7. Katz L., Merino M.J., Sakamoto H., Schwartz P.E. Endometrial stromal sarcoma a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors . Gynecol Oncol. 26:1987;87-97.
8. Tsukamoto N., Kamura T., Matsukuma K., et al. Endolymphatic stromal myosis a case with positive estrogen and progesterone receptors and good response to progestins (Case report) . Gynecol Oncol. 20:1985;120-128.
9. Sabini G., Chumas J.C., Mann W.J. Steroid hormone receptors in endometrial stromal sarcomas a biochemical and immunohistochemical study . Am Clin Pathol. 97:1992;381-386.
10. Tosi P., Sforza V., Santopietro R. Estrogen receptor content, immunohistochemically determined by monoclonal antibodies in endometrial stromal sarcoma. Obstet Gynecol. 73:1989;75-78.
11. Sutton G., Stehman F.B., Michael H., Young P.C.M., Ehrlich C.E. Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol. 68:1986;709-714.
12. Horowitz K., Rutherford T., Schwartz P.E. Hormone replacement therapy in women with sarcomas. CME J Gynecol Oncol. 1:1996;23-29.
13. Taylor A., Al-Azzawi F. Immunolocalization of oestrogen receptor beta in human tissues. J Mol Endocrinol. 24:2000;145-155.
14. Remmele W., Schicketanz K.H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer computer-assisted image analysis (QIC score) vs. subjective grading (IRS) . Pathol Res Pract. 189:1993;862-866.
15. Mor G. The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am J Reprod Immunol. 46:2001;298-307.
16. Nilsen J., Mor G., Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol. 43:2000;64-78.
17. Pujol P. Differential expression of estrogen receptor-alpha and beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res. 58:1998;5367-5373.
18. Beato M. Gene regulation by steroid hormones. Cell. 56:1989;335-344.
19. Evans H. Endometrial stromal sarcomas and poorly differentiated endometrial sarcoma. Cancer. 50:1982;2170-2182.
20. Mansi J., Ramachandra S., Wiltshaw E., Fisher C. Endometrial stromal sarcomas (case Report). Gynecol Oncol. 36:1990;113-118.
21. Gadducci A., Sartori E., Landoni F., Zola P., Maffino T., Urgesi A., et al. Endometrial stromal sarcoma analysis of treatment failures and survival . Gynecol Oncol. 63:1996;247-253.
22. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Treatment of endometrial stromal tumors. Gynecol Oncol. 36:1990;60-65.
23. Young R., Prat J., Scully R.E. Endometrioid stromal sarcomas of the ovary a clinicopathologic analysis of 23 cases . Cancer. 53:1984;1143-1155.
24. Kuiper G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 93:1996;5925-5930.
25. Warner M., Nilsson S., Gustafsson J.A. The estrogen receptor family. Curr Opin Obstet Gynecol. 11:1999;249-254.
26. Pelletier G., Labrie C., Labrie F. Localization of oestrogen receptor α, oestrogen receptor β and androgen receptors in the rat reproductive organs. J Endocrinol. 165:2000;359-370.
27. Pace P., Taylor J., Suntharalingam S., Coombes R.C., Ali S. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem. 272:1997;25832-25838.
28. Muramatsu M., Inoue S. Estrogen receptors how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun. 270:2000;1-10.
29. Kuiper G., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
30. Rutherford T., Brown W., Sapi E., Aschkenazi S., Munoz A., Mor G. Absence of estrogen receptor-β in metastatic ovarian cancer. Obstet Gynecol. 96:2000;417-421.
31. Ben-Hur H., Mor G., Insler V., Blickstein I., Amir-Zaltsman Y., Kohen F. Assessment of estrogen receptor distribution in human endometrium by direct immunofluorescence. Acta Obstet Gynecol Scand. 74:1995;97-102.
32. Giangrande P, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000;3102-15.